フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
LILLY (ELI) & COMPANY - Lilly Reports Q4 and Full-Year 2012 Results LILLY (ELI) & COMPANY - Lilly Reports Q4 and Full-Year 2012...
LILLY (ELI) & COMPANY - Miscellaneous - Other SEC Filings LILLY (ELI) & COMPANY - Miscellaneous - Other SEC Filings PR Newswire London...
LILLY (ELI) & COMPANY - Holding(s) in Company LILLY (ELI) & COMPANY - Holding(s) in Company PR Newswire London, January 24 Company...
LILLY (ELI) & COMPANY - Doc re Form 8-K Filings LILLY (ELI) & COMPANY - Doc re Form 8-K Filings PR Newswire London, January 24...
LILLY (ELI) & COMPANY - Director/PDMR Shareholding LILLY (ELI) & COMPANY - Director/PDMR Shareholding PR Newswire London, January 24...
LILLY (ELI) & COMPANY - Doc re Proxy Statement LILLY (ELI) & COMPANY - Doc re Proxy Statement PR Newswire London, January 24 Company...
LILLY (ELI) & COMPANY - 3rd Quarter Results LILLY (ELI) & COMPANY - 3rd Quarter Results PR Newswire London, January 24 Company Lilly...
LILLY (ELI) & COMPANY - 1st Quarter Results LILLY (ELI) & COMPANY - 1st Quarter Results PR Newswire London, January 24 Company Lilly...
LILLY (ELI) & COMPANY - Half-yearly Report LILLY (ELI) & COMPANY - Half-yearly Report PR Newswire London, January 24 Company Lilly...
LILLY (ELI) & COMPANY - Annual Financial Report LILLY (ELI) & COMPANY - Annual Financial Report PR Newswire London, January 24...
LILLY (ELI) & COMPANY - Annual Information Update 2012 LILLY (ELI) & COMPANY - Annual Information Update 2012 PR Newswire London...
LILLY (ELI) & COMPANY - Annual Information Update 2011 LILLY (ELI) & COMPANY - Annual Information Update 2011 PR Newswire London...
LILLY (ELI) & COMPANY - Annual Information Update 2010 LILLY (ELI) & COMPANY - Annual Information Update 2010 PR Newswire London...
LILLY (ELI) & COMPANY - Amyvid Approved in European Union LILLY (ELI) & COMPANY - Amyvid Approved in European Union PR Newswire London...
LILLY (ELI) & COMPANY - Phase III data results for empagliflozin LILLY (ELI) & COMPANY - Phase III data results for empagliflozin PR...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約